Skip to main content

Professor of Medicine, Division of Infectious Diseases
Site Leader, HIV Prevention and Treatment Clinical Trials Unit at Chapel Hill
Co-Lead, UNC Viral Hemorrhagic Fever Research Working Group


M.D., Robert Wood Johnson Medical School, Camden, NJ, 1991
Residency, Internal Medicine, Duke University Medical Center, 1994
Infectious Diseases Fellowship, UNC-Chapel Hill, 1998

Board Certifications

Internal Medicine ABIM, 1995-2005
Board Certified Infectious Diseases, 2000

Research Summary

Dr. Wohl’s research interests include serious viral infections including HIV and viral hemorrhagic fevers such as Ebola and Lassa fever. He has been conducting HIV-related research for over 20 years including studies of aging with HIV infection, as well as the nexus between mass incarceration and the HIV epidemic. As the Site Leader of the UNC HIV Prevention and Treatment Clinical Trials Unit at Chapel Hill he oversees a large team conducting cutting edge research on HIV therapeutics and prevention.

Since 2014, he has been conducting research in Liberia, West Africa investigating better treatments for Ebola as well as the sequelae experienced by survivors and the persistence of  Ebola virus in their bodies. Dr. Wohl has also been studying the natural history of Lassa fever in Liberia.

Dr. Wohl attends in the UNC Infectious Diseases, where he maintains a large continuity clinic.


Search PubMed

Wohl Biosketch

David Wohl, MD-covid-newsworthy-january-14-20